Levonorgestrel/Etinilestradiol Stada (Ethinylestradiol, Levonorgestrel)

The product contains levonorgestrel, a synthetic progestogen, and ethinylestradiol, a synthetic estrogen. Together they suppress the luteinizing hormone surge, inhibit ovulation, thicken cervical mucus to block sperm entry, and alter the endometrial lining, making implantation unlikely.

The dosage regimen is determined by the prescribing healthcare professional. Typically, one tablet is taken orally each day at the same time, following the specific pack schedule provided by the prescriber. Patients should follow the exact instructions on the label.

Levonorgestrel/Ethinylestradiol is contraindicated during pregnancy and should be discontinued if pregnancy occurs. Limited data are available for breastfeeding; most guidelines advise caution and recommend consulting a healthcare provider before use while nursing.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with progestin‑only pills, the combined formulation offers more consistent cycle control, reduced breakthrough bleeding, and additional benefits such as acne improvement. However, combined pills carry a higher risk of thromboembolic events, so individual risk factors must be evaluated.

Store the tablets at room temperature, below 25 °C, in the original blister pack or container. Keep them away from excess moisture, heat, and direct sunlight to maintain product stability throughout its shelf life.

The medication is taken orally as a tablet, usually once daily at the same time each day. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal discomfort.

Serious adverse events include venous thromboembolism (deep‑vein thrombosis, pulmonary embolism), arterial thrombosis (stroke, myocardial infarction), and severe allergic reactions. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should be evaluated carefully before use.

The product is contraindicated in women who are pregnant, have active breast cancer, a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or who are smokers aged 35 years or older. It should also be avoided in individuals with known hypersensitivity to either component.